Eli Lilly has been fined the largest amount for marketing fraud in US History, for their “off-label promotion” of the drug Zyprexa. According to CNNMoney.com, The company had promoted the drug as a treatment for dementia, including Alzheimer’s dementia in elderly people - for which it was never approved, the statement said. The company pleaded guilty to one misdemeanor charge as part of the settlement, it said in a statement. The sum includes a criminal fine of $515 million, which the Justice Department called “largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution.”
What do you think of this settlement? As a marketer, how would you have done things differently? Share with us here.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
